Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × regorafenib × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 15 Carcinoma, Hepatocellular 4 Sarcoma, Ewing 3 Sarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 MSI-H Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 HER2-positive Colorectal Cancer 1

Interventions

venetoclax 27 Azacitidine 25 fludarabine 22 Cyclophosphamide 15 fludarabine phosphate 14 Decitabine 13 Specimen Handling 12 Cytarabine 12 Whole-Body Irradiation 11 Busulfan 11 Biopsy 11 Stem Cell Transplantation 10 Tacrolimus 9 Mycophenolic Acid 9 decitabine and cedazuridine drug combination 8 Granulocyte Colony-Stimulating Factor 8 Methotrexate 7 Melphalan 7 Injections 7 Thiotepa 6 Peripheral Blood Stem Cell Transplantation 5 Idarubicin 5 Filgrastim 5 Daunorubicin 5 Blood Specimen Collection 5 Mesna 4 Cyclosporine 4 Cladribine 4 thymoglobulin 3 olutasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡